|
|
News Breaks
|
November 3, 2009
|
| 18:43 EDT |  | BMTI |
| theflyonthewall.com: | BioMimetic Therapeutics receives first marketing approval for Augment | | BioMimetic Therapeutics announced that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada. :theflyonthewall.com |
|
|
News For BMTI From The Last 14 Days Check below for free stories on BMTI the last two weeks.
There are 4 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 7, 2012
|
| 12:00 EDT |  | BMTI |
| theflyonthewall.com: | BioMimetic Therapeutics rises 15.2% | | BioMimetic Therapeutics is up 15.2%, or 31c, to $2.35 :theflyonthewall.com |
| | 10:00 EDT | | BMTI |
| | 09:00 EDT | | BMTI |
|
|
February 6, 2012
|
| 16:01 EDT | | BMTI |
|
|
|
|
|
Subscribe for More Information